Table 3.
TC50 toxic effects of Belamcanda extract in MDCK cells.
| Belamcanda extract (µg/mL) | Observed CPE |
Cumulative CPE |
Infection rate (%) | ||||
|---|---|---|---|---|---|---|---|
| Well count | CPE positive wells | CPE negative wells | Cumulative CPE positive wells | Cumulative CPE negative wells | Proportion of CPE positive wells | CPE positive rate (%) | |
| 20,000 | 6 | 6 | 0 | 17 | 0 | 17/17 | 100 |
| 10,000 | 6 | 6 | 0 | 11 | 0 | 11/11 | 100 |
| 5,000 | 6 | 4 | 2 | 5 | 2 | 5/7 | 71.43 |
| 2,500 | 6 | 1 | 5 | 1 | 7 | 1/8 | 12.5 |
| 1,250 | 6 | 0 | 6 | 0 | 13 | 0/13 | 0 |
| 625 | 6 | 0 | 6 | 0 | 19 | 0/19 | 0 |
CPE, cytopathic effect.